TITLE:
Trial of VLTS-589 in Subjects With Intermittent Claudication

CONDITION:
Intermittent Claudication

INTERVENTION:
Plasmid based Gene Transfer product-VLTS-589

SUMMARY:

      The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared
      with placebo, administered bilaterally to the lower extremities, in subjects with
      intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT)
      for subjects receiving VLTS-589 compared with subjects receiving placebo.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 40 Years to 80 Years
Criteria:

        Inclusion criteria:

          -  Men or women between 40 and 80 years of age,

          -  Must give informed consent,

          -  Current medical history of peripheral arterial disease, which includes the following
             symptoms: leg pain, leg discomfort or leg weakness

        Exclusion criteria:

          -  Ulcers or gangrene,

          -  History of cancer (except skin cancer) within the past 5 years,

          -  Participation in another clinical trial within 30 days of enrollment in this trial,

          -  Unwillingness or inability to comply with all study requirements
      
